Use of the IGF-I antisense strategy in the treatment of the hepatocarcinoma

Adv Exp Med Biol. 1998;451:35-42. doi: 10.1007/978-1-4615-5357-1_6.
No abstract available

MeSH terms

  • Animals
  • Antigens, Viral, Tumor / genetics
  • Antithrombin III / genetics
  • Antithrombin III / physiology
  • Apoptosis
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / therapy*
  • DNA, Antisense*
  • Genetic Therapy*
  • Humans
  • In Situ Nick-End Labeling
  • Insulin-Like Growth Factor I / genetics*
  • Liver Neoplasms / genetics
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy*
  • Liver Neoplasms, Experimental / genetics
  • Liver Neoplasms, Experimental / therapy*
  • Major Histocompatibility Complex
  • Mice
  • Mice, Transgenic
  • Promoter Regions, Genetic
  • Simian virus 40 / genetics
  • Tumor Cells, Cultured

Substances

  • Antigens, Viral, Tumor
  • DNA, Antisense
  • Insulin-Like Growth Factor I
  • Antithrombin III